All Companies
JNJ
Johnson & JohnsonPharmaceutical Preparations
$269.99updated Sep 19, 2026
Congressional trading profile for Johnson & Johnson (JNJ), covering 52 disclosed transactions by 21 lawmakers.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Total Trades
52
Politicians Trading
21
Last Traded
Aug 20, 2026
Price history
Congressional Trades
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| John BoozmanR | Sep 11, 2026 | Aug 20, 2026 | Sell | $1,001 - $15,000 | +0.98% |
| Alan ArmstrongR | Jul 21, 2026 | Mar 30, 2026 | Buy | $1,001 - $15,000 | +11.34% |
| Alan ArmstrongR | Jul 21, 2026 | Mar 27, 2026 | Buy | $15,001 - $50,000 | +12.29% |